|
Radiology HomeDepartment OverviewFacultyResidencyFellowshipsNeuroradiologyRochester CommunityLinks |
|
|
|||||||||||||||||
![]() |
|
| Figure 1: The optic tracts are thinned bilaterally on this axial T2 image. | |
![]() |
![]() |
| Figure 2: The absent septum pellucidum on this coronal T2 image results in a boxlike configuration of the anterior horn of the lateral ventricles. Also note the thin optic tracts. | Figure 3: Coronal T1 image demonstrates a thin corpus callosum. |
Diagnosis: Septo-optic dysplasia (DeMorsier’s Syndrome)
Discussion:
Septo-optic
dysplasia is an anterior midline congenital anomaly, affecting females
more than males (M:F=1:3), that consists of hypoplasia of the optic
nerves, along with absence (64%) or hypoplasia (34%) of the septum
pellucidum. The absent septum pellucidum causes a boxlike or squared
off appearance of the frontal horns of the lateral ventricles on
coronal
MR sequences. When the septum pellucidum is only hypoplastic, usually
the anterior portion is still present. It is because of this agenesis
or hypoplasia of the septum pellucidum that many consider this entity
to be classified as a type of holoprosencephaly. As such, it may
represent
the mildest form of the holoprosencephalies.
Along with the hypoplastic optic nerves, tracts,
and chiasm, there is also optic disc hypoplasia. The dysplastic optic
pathways can result in a range of visual dysfunctions, from mildly
diminished visual acuity to complete blindness. Visual nystagmus is
also not uncommon. Nevertheless, despite these abnormalities, some
patients may have no visual changes.
Agenesis or hypoplasia of the corpus callosum
as well as other white matter hypoplasia, manifested as enlarged
ventricles
and cisterns, are often associated with this abnormality. Science
is classically described in 50% of patients with this disorder.
Clinically, in addition to the visual disturbances,
patients with septo-optic dysplasia often present with seizures. There
is also an association with hypothalamic hypopituitarism (66%). This
may be manifested as diabetes insipidus or as growth retardation due
to diminished growth hormone.
References:
|
|
||
©Copyright University of Rochester Medical Center, 1999-2006. Disclaimer. For questions or suggestions concerning the content of these pages, contact the URMC Webmaster.